Task: Answer the multiple-choice question.
Question: Which drug exhibits a 23.625% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cc1ccc(OCCNC(=O)c2ccccc2SCC(=O)N2CCCC2)cc1
(b) Cc1ccc(Cl)cc1NS(=O)(=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C
Answer: b. Cc1ccc(Cl)cc1NS(=O)(=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(Cl)cc1NS(=O)(=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C
Cc1ccc(Cl)cc1NS(=O)(=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C
N-(5-chloro-2-methylphenyl)-7-methyl-2,3-dioxo-1,4-dihydroquinoxaline-6-sulfonamide